S
ev
eral prot
ein toxins, including th
e A chain of ricin (RTA),
ent
er mammalian c
ells by
endocytosis and subs
equ
ently r
each th
eir cytosolic substrat
es by translocation across th
e endoplasmicr
eticulum (ER) m
embran
e. To achi
ev
e this
export, such toxins
exploit th
e ER-associat
ed prot
ein d
egradation(ERAD) pathway but must
escap
e, at l
east in part, th
e normal d
egradativ
e fat
e of ERAD substrat
es. Toxinsthat translocat
e from th
e ER hav
e an unusually low lysin
e cont
ent. Sinc
e lysyl r
esidu
es ar
e pot
entialubiquitination sit
es, it has b
een propos
ed that this paucity of lysin
es r
educ
es th
e chanc
e of ubiquitinationand subs
equ
ent ubiquitin-m
ediat
ed prot
easomal d
egradation [Haz
es, B., and R
ead, R. J. (1997)
Biochemistry36, 11051-11054]. H
er
e w
e provid
e exp
erim
ental support for this hypoth
esis. Th
e two lysyl r
esidu
eswithin RTA w
er
e chang
ed to arginyl r
esidu
es. Th
eir r
eplac
em
ent in RTA did not hav
e a significantstabilizing
eff
ect, sugg
esting that th
e endog
enous lysyl r
esidu
es ar
e not th
e usual sit
es for ubiquitinattachm
ent. How
ev
er, wh
en four additional lysin
es w
er
e introduc
ed into RTA in a way that did notcompromis
e th
e activity, structur
e, or stability of th
e toxin, d
egradation was significantly
enhanc
ed.Enhanc
ed d
egradation r
esult
ed from ubiquitination that pr
edispos
ed th
e toxin to prot
easomal d
egradation.Tr
eatm
ent with th
e prot
easom
e inhibitor
clasto-lactacystin
![](/imag<font color=)
es/gifchars/b
eta2.gif" BORDER=0 ALIGN="middl
e">-lacton
e incr
eas
ed th
e cytotoxicity of th
elysin
e-rich RTA to a l
ev
el approaching that of wild-typ
e ricin. Th
e introduction of four additional lysylr
esidu
es into a s
econd ribosom
e-inactivating prot
ein, abrin A chain, also dramatically d
ecr
eas
ed th
ecytotoxicity of th
e holotoxin compar
ed to wild-typ
e abrin. This
eff
ect could also b
e r
ev
ers
ed by prot
easomalinhibition. Our data support th
e hypoth
esis that th
e evolution of a low lysin
e cont
ent is a d
egradation-avoidanc
e strat
egy for toxins that r
etrotranslocat
e from th
e ER.